Close Menu

Heating Up

The Boston Globe notes a recent spike in biotech merger and acquisitions. The deals going through at Inverness, Biogen, and Takeda follow an 18-month-long lull. "When you've had a cycle of fear and now we're seeing real signs that growth is coming," says Kevin Gorman from Putnam Associates, "if you can pick up an asset that fits your strategy, and you can pick it up at a decent price, why not?"

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.